The Debt to Equity Ratio is a company’s total liabilities divided by its shareholder equity. It's the degree to which a company is financing its operations through debt v/s wholly owned funds

Lower than Industry Debt to Equity Ratio

Current ratio measures a company’s ability to pay short-term obligations. Higher is better

Higher than Industry Current Ratio

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Higher than Industry Revenue Growth

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Constant Market Share

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Higher than Industry Net Income

The EBITDA margin is the percent of revenue that the company retains after incurring all the direct and operational costs of the business

Lower than Industry EBITDA Margin

The net profit margin is net income or profit generated as a percentage of revenue and illustrates how much of each rupee in revenue translates to profit

Lower than Industry Net Profit Margin

Y-o-y growth in the total revenue represents increased potential for the company to increase their market share.Total revenue for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Increasing Total Revenue

Y-o-y growth in the net income represents increased profitability of the company.Net profit for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Decreasing Net Profit

Increasing EBITDA margin indicates increased profit efficiency without taking into account financial, accounting or tax implications

Constant EBITDA Margin

Increasing Net profit margins indicates the increasing profit to the shareholders with each unit of revenue

Constant Net Profit Margin

Y-o-y growth in the EBITDA represents how efficiently the company manages its expenses.EBITDA for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Decreasing EBIDTA

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Gennex Laboratories Limited is engaged in manufacturing of bulk drugs, intermediates and biotech products. Its product portfolio is spread over various product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. 

Financial Year	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	TTM
Total Revenue	35.20	32.09	38.77	42.03	44.69	56.58	56.68	60.17	62.59	72.03
Raw Materials	23.86	20.29	24.24	24.41	26.88	36.31	35.13	35.18	41.23	65.58
Power & Fuel Cost	1.92	1.87	2.21	1.97	2.26	2.85	3.30	3.01	3.17
Employee Cost	3.07	3.36	4.12	4.96	5.55	6.12	6.81	7.21	6.97
Selling & Administrative Expenses	2.79	2.20	2.39	3.13	3.01	4.23	3.34	3.44	3.43
Operating & Other expenses	1.72	2.15	1.44	2.92	3.88	2.27	3.79	4.65	1.03
EBITDA	1.84	2.22	4.37	4.64	3.11	4.80	4.31	6.68	6.76	6.45
Depreciation/Amortization	0.82	0.89	0.84	0.84	0.92	0.98	1.00	0.88	0.79	1.07
PBIT	1.02	1.33	3.53	3.80	2.19	3.82	3.31	5.80	5.97	5.38
Interest & Other Items	0.32	0.48	0.50	0.71	0.73	0.79	0.75	0.74	0.88	0.70
PBT	0.70	0.85	3.03	3.09	1.46	3.03	2.56	5.06	5.09	4.68
Taxes & Other Items	0.49	0.19	0.69	0.40	0.62	0.80	0.69	1.02	1.17	1.02
Net Income	0.21	0.66	2.34	2.69	0.84	2.23	1.87	4.04	3.92	3.66
EPS	0.02	0.05	0.18	0.21	0.06	0.17	0.14	0.30	0.30	0.28
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Gennex Laboratories Ltd

Gennex Laboratories Ltd

Scorecard

Standalone
Financial Statements

What is an income statement?

Income Statement
Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Company Updates

Gennex Laboratories Ltd

Scorecard

Standalone Financial Statements

What is an income statement?

Income StatementIndustry refers to the sub-sector this company belongs to.

Higher than Industry Revenue GrowthA higher-than-industry revenue growth represents increased potential for the company to increase their market share

Constant Market ShareMarket share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Higher than Industry Net IncomeNet income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Company Updates

Standalone
Financial Statements

Income Statement
Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is